Association of molecular senescence markers in late-life depression with clinical characteristics and treatment outcome

Authors

Breno S Diniz, University of Connecticut School of Medicine and Dentistry
Benoit H Mulsant, University of Toronto
Charles F Reynolds, University of Pittsburgh
Daniel M Blumberger, University of Toronto
Jordan F Karp, University of Arizona
Meryl A Butters, University of Pittsburgh
Ana Paula Mendes-Silva, University of Toronto
Erica L Vieira, University of Toronto
George Tseng, University of Pittsburgh
Eric J Lenze, Washington University School of Medicine in St. Louis

Journal

JAMA Network Open

Publication Date

6-1-2022

Volume

5

Issue

6

First Page

e2219678

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2022.19678

Rights and Permissions

Diniz BS, Mulsant BH, Reynolds CF, et al. Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome. JAMA Netw Open. 2022;5(6):e2219678. doi:10.1001/jamanetworkopen.2022.19678. This is an open access article distributed under the terms of the CC-BY License.

Recommended Citation

Diniz, Breno S; Mulsant, Benoit H; Reynolds, Charles F; Blumberger, Daniel M; Karp, Jordan F; Butters, Meryl A; Mendes-Silva, Ana Paula; Vieira, Erica L; Tseng, George; and Lenze, Eric J, "Association of molecular senescence markers in late-life depression with clinical characteristics and treatment outcome." JAMA Network Open. 5, 6. e2219678 (2022).
https://digitalcommons.wustl.edu/oa_4/566